Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Pharmacovigilance Compliance Policy

Posted on By

SOP for Pharmacovigilance Compliance Policy

Guidelines for Pharmacovigilance Compliance

1) Purpose

The purpose of this SOP is to outline the policies and procedures for ensuring compliance with pharmacovigilance regulations and guidelines to ensure patient safety and regulatory adherence.

2) Scope

This SOP applies to all employees involved in pharmacovigilance activities, including the collection, evaluation, and reporting of adverse events and other safety information.

3) Responsibilities

The Pharmacovigilance (PV) team, Quality Assurance (QA) department, and all relevant staff are responsible for adhering to this compliance policy. The PV team is responsible for monitoring compliance and reporting any deviations.

See also  SOP for Pharmacovigilance Case Assessment

4) Procedure

4.1 Policy Adherence

  1. All employees must familiarize themselves with current pharmacovigilance regulations and guidelines relevant to their roles.
  2. Regular training sessions must be conducted to ensure continuous compliance with pharmacovigilance standards.
  3. Compliance with pharmacovigilance policies must be documented and reviewed periodically.

4.2 Monitoring and Auditing

  1. Conduct regular internal audits to assess compliance with pharmacovigilance procedures.
  2. Document findings and corrective actions from audits in a timely manner.
  3. Implement necessary changes based on audit results to improve compliance.

4.3 Reporting and Documentation

  1. Ensure all adverse events are reported in accordance with regulatory requirements.
  2. Maintain accurate and up-to-date records of all pharmacovigilance activities.
  3. Submit periodic compliance reports to regulatory authorities as required.
See also  SOP for Pharmacovigilance Post-Marketing Surveillance

4.4 Continuous Improvement

  1. Regularly review and update pharmacovigilance policies and procedures to reflect new
regulations and best practices.
  • Encourage feedback from staff to identify areas for improvement in pharmacovigilance practices.
  • Implement changes promptly to enhance compliance and patient safety.
  • 5) Abbreviations, if any

    Pv – Pharmacovigilance

    6) Documents, if any

    Pharmacovigilance training records, audit reports, compliance reports.

    7) Reference, if any

    Relevant regulatory guidelines such as ICH E2E Pharmacovigilance Planning, FDA guidelines, EMA guidelines.

    8) SOP Version

    Version 1.0

    Pharmacovigilance Tags:Pharmacovigilance adverse event reporting SOP, Pharmacovigilance audit preparation SOP, Pharmacovigilance case processing SOP, Pharmacovigilance compliance monitoring SOP, Pharmacovigilance compliance SOP, Pharmacovigilance data collection SOP, Pharmacovigilance data privacy SOP, Pharmacovigilance database management SOP, Pharmacovigilance documentation management SOP, Pharmacovigilance guidelines, Pharmacovigilance literature review SOP, Pharmacovigilance medical review SOP, Pharmacovigilance periodic reporting SOP, Pharmacovigilance procedure document, Pharmacovigilance quality management SOP, Pharmacovigilance regulatory reporting SOP, Pharmacovigilance risk assessment SOP, Pharmacovigilance risk management plan SOP, Pharmacovigilance risk minimization SOP, Pharmacovigilance safety reporting SOP, Pharmacovigilance signal detection SOP, Pharmacovigilance signal management SOP, Pharmacovigilance SOP template, Pharmacovigilance system master file SOP, Pharmacovigilance training program SOP

    Post navigation

    Previous Post: SOP for Formulation Development Team Formation
    Next Post: SOP for Maintaining Sterility in Aerosol Production

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version